Meta-analysis of (single-cell method) benchmarks reveals the need for extensibility and interoperability
Genome Biology volume 24, Article number: 119 (2023)
Computational methods represent the lifeblood of modern molecular biology. Benchmarking is important for all methods, but with a focus here on computational methods, benchmarking is critical to dissect important steps of analysis pipelines, formally assess performance across common situations as well as edge cases, and ultimately guide users on what tools to use. Benchmarking can also be important for community building and advancing methods in a principled way. We conducted a meta-analysis of recent single-cell benchmarks to summarize the scope, extensibility, and neutrality, as well as technical features and whether best practices in open data and reproducible research were followed. The results highlight that while benchmarks often make code available and are in principle reproducible, they remain difficult to extend, for example, as new methods and new ways to assess methods emerge. In addition, embracing containerization and workflow systems would enhance reusability of intermediate benchmarking results, thus also driving wider adoption.
Given the rapid development and uptake of new technologies in biology (e.g. high-throughput DNA sequencing, single-cell assays and imaging technologies), methodologists are presented with nearly unlimited opportunities to apply or develop computational tools to process, model, and interpret large-scale datasets across a wide range of applications. Unsurprisingly, the data explosion [1, 2] is mirrored by a massive increase in the number of computational methods; for example, at time of writing, 1318 are listed in a database of tools for the analysis of single-cell RNA-seq data [3, 4] and more than 370 tools are listed for the analysis of spatial omics data . This imposes challenges for determining what tools to use for discovery . In particular, researchers often need to convince themselves that they develop or use performant tools in their research, and a typical approach is via formal benchmarks. Benchmarks can be decomposed into five steps: (1) formulating a computational task (or subtask) that will be investigated (e.g. calling differentially expressed genes); (2) collecting reference datasets by either generating (realistic) synthetic datasets or using ground truth derived from experimental data; (3) defining performance criteria (e.g. sensitivity, specificity); (4) evaluating a representative set of methods via a set of performance criteria across multiple reference datasets; and (5) formulating conclusions and guidelines.
In terms of developing and disseminating new methods, the minimum requirement of quality is usually that the new approach provides a benefit against existing approaches. However, the current standard allows developers to be their own “judge, jury and executioner” , giving them some freedom to choose the settings and the evaluations used in the benchmark. There is a notable tension here, since methodologists that want to develop high-quality novel approaches may also be under pressure to publish . One can argue that the risk of biases and over-optimistic evaluations of new approaches is minimized by the standard scientific review process; however this is also known to have its challenges . Ultimately, it is almost a foregone conclusion that a newly proposed method will report comparatively strong performance [7, 10]. Thus, claims from individual method development papers need to be scrutinized, preferably from a neutral (i.e. independent) standpoint [11, 12]. Neutral benchmarking appears to be a popular approach, since over 60 benchmarks have been conducted for single-cell data analysis alone (see below and Additional file 1). But even if done neutrally, the community may still want a mechanism to challenge, extend, or personalize the assessments (e.g. update/add reference datasets, run methods with alternative parameters, use different metrics, rank methods differently).
Neutral benchmarking shares common ground with community “challenges” for consolidating the state-of-the-art. In some subfields of computational biology, there is a long history of such challenges, such as the biannual CASP (Critical Assessment of Structure Prediction)  and DREAM (Dialogue on Reverse Engineering Assessment and Methods) challenges , where participants are invited to propose solutions to a predefined problem. The challenge model is growing in success, including leaderboards that give real-time feedback, but these can sometimes reinforce a narrow view of performance (e.g. a single measure of performance on a single dataset . In addition, for a challenge to be conceptualized in the first place, the community needs to formalize and frame existing problems, have access to suitable reference datasets, gather indications that the challenge can be solved, and only then assess if current technologies and methods would be able to solve it. This necessarily requires some common ground and knowledge in the field, which is often gained by neutral benchmarking studies. Although community challenges engage communities and innovation, they are typically time-gated in their scope, whereas one could also imagine benchmarking as a continuous process where challenges are integrated into the subfield’s trajectory. Initiatives in this direction include OpenEBench , which provides a computing platform and infrastructure for benchmarking events, and’Open Problems in Single Cell Analysis’, which is focused on formalizing (single-cell data analysis) tasks to foster innovation in method development while providing infrastructure and datasets such that new methods can be tested [17, 18].
There are several obstacles related to running and using the results of benchmarks. In fast-moving subfields, benchmark results become rapidly out-of-date and, in some cases, competing methods never get directly compared because they are developed simultaneously. Current benchmarks are always a snapshot in time, while tool development is continuous. There are common components of most benchmarks, such as reference datasets, a set of methods and metrics to score their performance, but there are typically no pervasive standards for the system or strategy of benchmarking in computational biology, except for those predefined by challenges. This lack of standards can, for example, lead to different rankings of the same methods for the same task [19,20,21]. Similarly, shortcomings of existing performance metrics may be discovered subsequent to earlier benchmarks . Another area in which benchmarks underdeliver is the interpretation of performance results. Benchmark authors (or challenge organizers) generally get to make all the decisions about how the performance evaluation is conducted (e.g. how a ranking is determined, given multiple criteria).
Altogether, it remains an open question whether computational biology has reached a benchmarking optimum, achieving fair comparisons in a timely, independent, and continuous manner, while also keeping the barrier low enough for colleagues, including those in adjacent fields, to participate. In this report, we review current benchmarking practices in a subfield of genome biology (single-cell data analysis) to get an understanding of where the current state-of-the-art is, and based on our findings, we postulate what elements of benchmarking would be considered desirable for the future.
State-of-the-art in benchmarking
To understand the current state of practice in benchmarking studies in computational biology, we crowdsourced a list of single-cell method benchmarks (studies were selected by the project team from the period of 2018–2021 as exhaustively as possible on the basis of having at least a preprint posted, and involving the comparison of computational methods for some form of single-cell data, and not a primary method publication; see Additional file 1 for the list of studies). We then designed a questionnaire to query various attributes of a benchmark study (see Methods, Additional file 2) and crowdsourced the review of these benchmarks. We focused on single-cell methods because it is an active area of methodological research, with an acute method explosion [3, 4], and a large number of benchmarks have been conducted. The list of questions asked for each benchmark includes both factual (e.g. “Whether synthetic data is available”) and opinion (e.g. “Degree to which authors are neutral”) assessments. Overall, we queried the scope, extensibility, neutrality, open science, and technical features of each benchmark. We required that at least two reviewers answer the questionnaire for each benchmark, and in the case of large discrepancies between responses (disagreement in a factual question or large difference in opinion), results were consolidated manually by a third reviewer (see Additional file 1 for consolidated responses, Additional file 3 for original responses). Questions were organized into two topics: (1) overall design of the benchmark and (2) code and data availability and technical aspects.
Overall design of benchmarks
The overall design of the 62 surveyed single-cell benchmarks, including the number of datasets, methods, or criteria used for the comparison or the neutrality of the authors, was assessed. The number of benchmark datasets varied greatly, with 2 benchmarks using only 1 dataset and 1 benchmark using thousands of simulated datasets (median = 8). Likewise, the number of methods evaluated varied from 2 to 88 (median = 9) for the chosen task. Finally, the number of evaluation criteria, defined here as numerical metrics to compare method results against a ground truth, varied from 1 to 18 (median = 4), showing that current benchmarks tend to include more methods and datasets than evaluation criteria (Fig. 1A). The range of analysis tasks covered by benchmarks mirrors quite well the range of tools available [3, 4]. A notable exception is the category of visualization tasks, accounting for 40% of the available tools but formally benchmarked only once (Fig. 1B). Seventy-two percent of the manuscripts were first released as preprints and 66% tested only default parameters (Fig. 1C). We also enquired about the neutrality of the authors, defined as whether the authors of the benchmark were involved in one or several of the methods evaluated. For more than 60% of the benchmarks, the authors were completely independent of the evaluated methods (Fig. 1D); neutrality is a desired attribute, although not absolutely required. More than 75% of benchmarks also assessed secondary measures (Additional file 4 Figure S1), such as runtime, memory usage, and scalability.
Code/data availability, reproducibility, and technical aspects
Also important for the uptake of benchmarking results is the open science and reproducibility practices of the studies. Thus, the second group of questions related to the availability of data, code, and results as well as technical aspects. Figure 2A gives an overview of the availability of the different levels of data for benchmarking studies, highlighting that input (often ground-truth-including) data is frequently available (97% of studies). However, intermediate results, including outputs of methods run on datasets and performance results were only sparsely available at 19% and 29%, respectively. For studies that generated simulated data, less than half (19/46 articles) made their synthetic data available. Only 10% of benchmarks provided performance results in an explorable format. On the technical side, most benchmarks reported software versions of the methods being evaluated (68%), although provenance tracking (tracking of inputs, outputs, parameters, software versions, etc.) was not explicitly used. Another aspect of reproducible practice is related to workflow tools that are used to orchestrate the datasets through methods and metrics. Although their use in computational biology is increasing , we observed that less than 25% of the surveyed benchmarks used any form of them (see Fig. 2B). In a similar vein, containerization of software environments is quite mature in computational biology  but is rarely utilized in benchmarking (8% of studies). Concerning the methods that are compared, R and Python remain the dominant programming languages for single-cell methods, mirroring the summaries in the scrna-tools database ; see also Additional file 4 Figure S1.
We next scored the degree to which code is available on a scale of 1 to 5 (Fig. 2C) where 1 means ‘not at all’ and 5 means ‘completely’. For over 75% of the benchmarks, code was fully or partially available, such as in a GitHub repository, although there are clearly different levels of completeness and description. We also gathered opinions on how extensible the available code is (e.g. how easy it is to incorporate an additional dataset, method or evaluation criterion; see Fig. 2C); among the 47 studies sharing code, only two studies received a high score for extensibility.
Explicit code licencing is somewhat sporadic for benchmark studies (Fig. 2D); of the 47 studies that made code available, 19 (40%) did not specify a licence. This can become an important consideration when re-using (public but licenced) code for building data analysis pipelines or extending benchmarks. Of those benchmarks that specified a licence, the free software MIT and GPLv3 appeared to be the dominant ones.
Taken together, our meta-analysis shows that most benchmarks results are at least in principle reproducible, since code and input data are shared. However, a fully reproducible analysis would also require information about the software environment (e.g. operating system, libraries, packages) or an available container, which are sometimes documented, but often not readily available in the benchmarks that we evaluated. Thus, a significant amount of redundant work would be required to re-establish or extend the vast majority of surveyed benchmarks.
Benchmarking of omics tools has evolved to become standard practice and remains a crucial part of the development cycle of computational methods. However, the current standard of benchmarking still leaves considerable room for improvement. For example, benchmarks can become out-of-date rapidly, especially in fast-moving subfields such as genomic data analysis. A better standard would involve updating and running benchmarking continuously as new methods emerge and, importantly, as better metrics become apparent. The computational biology community has for a long time been liberal about making code available , mirroring the genomics community in making data available , but the current standard in benchmarking is often not much more than a code dump, i.e. a minimal record of what was done. Ideally, methodologists get access to not only code and input data but also full software environments as well as modular workflow systems to orchestrate the running of methods on datasets and evaluations of results against a ground truth. Ultimately, many of the components that form a benchmark (datasets, methods, evaluation metrics) could be potentially re-used (e.g. ground truth datasets re-purposed for a different computational task). What is lacking right now is a general interoperability between components. Across current benchmarks, there is (typically) no mechanism to add new methods, datasets, or metrics, which is an important consideration, since we want to update and push the state-of-the-art for developers, researchers and consumers of our methods.
Seamless and eternal extensibility or reproducibility can be challenging to establish and maintain indefinitely, especially for single research groups and because software toolchains used in computational biology are constantly in flux. The complete absence of provenance tracking also highlights that the intermediate results of a benchmark are not currently being directly reused. For example, if a developer wanted to evaluate their method within the context of an existing benchmark, they would only have access to the bare minimum (usually just the reference datasets and some code); nonetheless, they are expected to re-run all previous methods essentially reconstructing the benchmark from scratch. This signals an opportunity to make intermediate results available in a systematic way, and use provenance tracking more broadly, whereby the results of methods run on datasets are recorded (as well as metric calculations comparing the results to the ground truth), together with the relevant parameters, such that method developers need only to re-execute relevant new components of a workflow. Reusability and extensibility of benchmarks would not only benefit users but also increase the visibility of published benchmarks, not simply a static and dated view of the field. A related point is software environments, since an ongoing challenge in computational biology is to onboard new methods across diverse computing systems, due to possibly different library requirements (e.g. Python version or Bioconductor release) of each software tool. Here, containerization  represents a currently untapped opportunity to systematize this for research pipelines as well as benchmarking studies.
Another area where users (data analysts, method developers) could directly interact with the benchmark data products is in the interpretation of performance. With access to the various assessment criteria, ranking strategies could be established that are tailored to specific use cases and experimental settings, instead of that chosen in advance by the benchmarking team.
Despite the considerable time and effort required to set up a serious benchmark (e.g. collecting and standardizing datasets with ground truth, installing and onboarding methods, defining and running metrics), it is still most common to build a benchmark from scratch instead of extending existing benchmarks. To put in context, the single-cell community has developed over 80 methods to infer trajectories and over 40 methods to call differentially expressed genes , but there are seemingly few systems to orchestrate (create, extend, and run) neutral benchmarks. The burden of implementing extensible and continuously updated benchmarks does not necessarily need to be on the side of the benchmarker alone, since most benchmarks employ a similar structure (e.g. datasets, methods, metrics) and could use a general benchmarking orchestration system.
Although here we have focused on stand-alone benchmarks, every method developer is obligated to compare their approach to existing ones and also here a systematic approach has the potential to achieve considerable efficiency. Method developers could use an established (vetted) benchmark to evaluate their method, while introducing considerable time savings, avoiding some of the problems of self-assessment , and increasing transparency while preserving the value of benchmarks for end users.
The future of benchmarking
Besides having a modern technical implementation to organize benchmarks, it will be important that the community populates the system with high-quality tests of methods and finds strategies to constantly re-monitor the suitability of such tests, in a both systematic and community-informed way. However, several questions remain, such as who is responsible for the cost of computation, how to decide on the composition of high-quality tests of methods, and how to best combine performance metrics to rank methods.
In this article, we identified several bottlenecks in current benchmarking policies, mainly related to reproducibility, extensibility, and achieving access to useful content. Taken together, to achieve a more transparent and impactful methods assessment ecosystem, we suggest that systematization of benchmarks through containerization, workflow tools, and provenance tracking with access to the full results of a benchmark would be required. A comprehensive list of issues and recommendations for benchmarking identified in this article is available in Table 1, but other guidelines were already covered by others [11, 12, 27, 28]. Notably, a set of principles to achieve higher quality and sustainability, FAIRsoft, was recently developed for research software , coupled with a scoring system scheme that allows a more objective assessment and evaluation of FAIR (Findable, Accessible, Interoperable, Reusable) principles; this strategy could also be applied to benchmarks. Our recommendations also echo a recent call to evaluate computational methods using a common platform . Several initiatives are in motion here, such as ‘Open Problems in Single-Cell Analysis’ and OpenEBench [16, 17], and other tools may emerge for achieving this desired interoperability. We believe that if benchmark authors and method developers start embracing these tools, future benchmarks will have an enduring impact in guiding computational methods towards a more structured and comprehensive science.
To perform the survey, we first gathered a list of published benchmarks in the field of single-cell data analysis. The list was crowdsourced by the project team using search engines, literature searches, and our own benchmarks, as well as a call on Twitter. Selected benchmarks had to have at least a preprint published and should not showcase a new computational method. Sixty-two benchmarks covering 19 analysis tasks were gathered and used for the rest of the analysis (see Additional file 1 for the list of studies).
A questionnaire was designed before the collection of data to evaluate different aspects of the benchmarks, grouped into ‘General information’, ‘Code/data availability’, and ‘Technical aspects’ (see Additional file 2). The latter two categories were merged into ‘Code, data availability and technical aspects’ in the manuscript for more clarity and because they were regrouping information from a similar aspect. The questions covered both factual and opinion assessments. The factual questions could be numerical (“Number of methods evaluated”), categorical (“Type of workflow used”), or semi-open (e.g.: answers to “What secondary measures were assessed?” could be of “Code quality”, “Installation” or a free answer to specify). All reviewers are students, postdocs, or group leaders actively involved in computational biology methods development. Several of the reviewed benchmarks were performed by our research group; however, to ensure neutrality, we allocated reviewers to be someone that was not directly involved. Except for this constraint, the reviewers could freely assign themselves to any benchmarks that corresponded to their own domain of expertise or interest. Each benchmark was reviewed at least twice by two reviewers (see Additional file 3 for original responses). Some questions received a high level of concordance among the two reviews (example, “Type of workflow system used” and “Whether input data used by the methods is available”) while some received a lower level of concordance (“Degree to which code to re-run benchmark is extensible”, “What secondary measures were assessed?”). To resolve discrepancies, we employed a third reviewer to harmonize one or several questions across all benchmarks. Most discrepancies came about from unanswered questions, adding text to numerical answers, or simple errors (e.g. missing that a code repository was made available). A small number of discrepancies arose from underestimations due to relevant information being missed during one of the reviews (e.g. “Degree to which authors are neutral”, where some reviewers missed an author’s contribution to one of the evaluated methods), while other harmonizations required a re-analysis of the answers and a discussion with individual reviewers (e.g. “Degree to which code to re-run benchmarks is extendible”). The analysis presented in this manuscript was performed on the harmonized answers.
Availability of data and materials
The code to organize, consolidate, monitor, and analyse the benchmark reviews is available from https://github.com/markrobinsonuzh/sc_benchmark_metaanalysis and a snapshot is posted at Zenodo (https://doi.org/10.5281/zenodo.7097767) . The survey form, survey responses, and list of benchmarks with collated survey responses are available as additional files 1, 2, and 3, and on Zenodo (https://doi.org/10.5281/zenodo.7733753) .
Schatz MC. Biological data sciences in genome research. Genome Res. 2015;25(10):1417–22.
Svensson V, da Veiga Beltrame E, Pachter L. A curated database reveals trends in single-cell transcriptomics. Database. 2020;2020. Available from: https://doi.org/10.1093/database/baaa073.
Zappia L, Phipson B, Oshlack A. Exploring the single-cell RNA-seq analysis landscape with the scRNA-tools database. PLoS Comput Biol. 2018;14(6):e1006245.
Zappia L, Theis FJ. Over 1000 tools reveal trends in the single-cell RNA-seq analysis landscape. Genome Biol. 2021;22(1):301.
Moses L, Pachter L. Museum of spatial transcriptomics. Nat Methods. 2022;19(5):534–46.
Dance A. Which single-cell analysis tool is best? Scientists offer advice. Nature. 2022;612(7940):577–9.
Norel R, Rice JJ, Stolovitzky G. The self-assessment trap: can we all be better than average? Mol Syst Biol. 2011;11(7):537.
Grimes DR, Bauch CT, Ioannidis JPA. Modelling science trustworthiness under publish or perish pressure. R Soc Open Sci. 2018;5(1):171511.
Tennant JP, Ross-Hellauer T. The limitations to our understanding of peer review. Res Integr Peer Rev. 2020;30(5):6.
Buchka S, Hapfelmeier A, Gardner PP, Wilson R, Boulesteix AL. On the optimistic performance evaluation of newly introduced bioinformatic methods. 2021. Available from: https://doi.org/10.31222/osf.io/pkqdx.
Mangul S, Martin LS, Hill BL, Lam AKM, Distler MG, Zelikovsky A, et al. Systematic benchmarking of omics computational tools. Nat Commun. 2019;10(1):1393.
Weber LM, Saelens W, Cannoodt R, Soneson C, Hapfelmeier A, Gardner PP, et al. Essential guidelines for computational method benchmarking. Genome Biol. 2019;20(1):125.
Kryshtafovych A, Schwede T, Topf M, Fidelis K, Moult J. Critical assessment of methods of protein structure prediction (CASP)-Round XIV. Proteins. 2021;89(12):1607–17.
Stolovitzky G, Monroe D, Califano A. Dialogue on reverse-engineering assessment and methods: the DREAM of high-throughput pathway inference. Ann N Y Acad Sci. 2007;1115:1–22.
Open Problems - Multimodal Single-Cell Integration. [cited 2022 Aug 26]. Available from: https://www.kaggle.com/competitions/open-problems-multimodal/leaderboard.
Capella-Gutierrez S, de la Iglesia D, Haas J, Lourenco A, Fernández JM, Repchevsky D, et al. Lessons learned: recommendations for establishing critical periodic scientific benchmarking. bioRxiv. 2017 [cited 2020 Jan 23]. p. 181677. Available from: https://www.biorxiv.org/content/10.1101/181677v1.
Lance C, Luecken MD, Burkhardt DB, Cannoodt R, Rautenstrauch P, Laddach A, et al. Multimodal single cell data integration challenge: results and lessons learned. bioRxiv. 2022 [cited 2022 Aug 16]. p. 2022.04.11.487796. Available from: https://www.biorxiv.org/content/10.1101/2022.04.11.487796v1.
Luecken MD, Burkhardt DB, Cannoodt R, Lance C, Agrawal A, Aliee H, et al. A sandbox for prediction and integration of DNA, RNA, and proteins in single cells. 2022 [cited 2022 Aug 16]. Available from: https://openreview.net/pdf?id=gN35BGa1Rt.
Luecken MD, Büttner M, Chaichoompu K, Danese A, Interlandi M, Mueller MF, et al. Benchmarking atlas-level data integration in single-cell genomics. Nat Methods. 2022;19(1):41–50.
Chazarra-Gil R, van Dongen S, Kiselev VY, Hemberg M. Flexible comparison of batch correction methods for single-cell RNA-seq using BatchBench. Nucleic Acids Res. 2021; Available from: https://doi.org/10.1093/nar/gkab004.
Tran HTN, Ang KS, Chevrier M, Zhang X, Lee NYS, Goh M, et al. A benchmark of batch-effect correction methods for single-cell RNA sequencing data. Genome Biol. 2020;21(1):12.
Lütge A, Zyprych-Walczak J, Brykczynska Kunzmann U, Crowell HL, Calini D, Malhotra D, et al. CellMixS: quantifying and visualizing batch effects in single-cell RNA-seq data. Life Sci Alliance. 2021;4(6). Available from: https://doi.org/10.26508/lsa.202001004.
Perkel JM. Workflow systems turn raw data into scientific knowledge. Nature. 2019;573(7772):149–50.
Gruening B, Sallou O, Moreno P, da Veiga Leprevost F, Ménager H, Søndergaard D, et al. Recommendations for the packaging and containerizing of bioinformatics software. F1000Res. 2018;7. Available from: https://doi.org/10.12688/f1000research.15140.2.
Deshpande D, Sarkar A, Guo R, Moore A, Darci-Maher N, Mangul S. A comprehensive analysis of code and data availability in biomedical research. OSF Preprints; 2021. Available from: https://doi.org/10.31219/osf.io/uz7m5.
Byrd JB, Greene AC, Prasad DV, Jiang X, Greene CS. Responsible, practical genomic data sharing that accelerates research. Nat Rev Genet. 2020;21(10):615–29.
Mangul S, Mosqueiro T, Abdill RJ, Duong D, Mitchell K, Sarwal V, et al. Challenges and recommendations to improve the installability and archival stability of omics computational tools. PLoS Biol. 2019;17(6):e3000333.
Aniba MR, Poch O, Thompson JD. Issues in bioinformatics benchmarking: the case study of multiple sequence alignment. Nucleic Acids Res. 2010;38(21):7353–63.
del Pico EM, Gelpi JL, Capella-Gutiérrez S. FAIRsoft - A practical implementation of FAIR principles for research software. bioRxiv. 2022 [cited 2023 Jan 9]. p. 2022.05.04.490563. Available from: https://www.biorxiv.org/content/, https://doi.org/10.1101/2022.05.04.490563v2.full.
Czarnewski P, Mahfouz A, Calogero RA, Palagi PM, Portell-Silva L, Gonzalez-Uriarte A, et al. Community-driven ELIXIR activities in single-cell omics. F1000Res. 2022;11(869):869.
Sonrel A, Luetge A, Soneson C, Mallona I, Germain PL, Knyazev S, et al.. Code to support the meta analysis of single cell benchmarks paper. https://github.com/markrobinsonuzh/sc_benchmark_metaanalysis. Snapshot at https://doi.org/10.5281/zenodo.7097767 (2023).
Sonrel A, Luetge A, Soneson C, Mallona I, Germain PL, Knyazev S, et al.. Meta-analysis of (single-cell method) benchmarks reveals the need for extensibility and interoperability (survey form, survey responses and list of benchmarks with collated survey responses). https://doi.org/10.5281/zenodo.7733753 (2023).
The review history is available as additional file 5.
Peer review information
Anahita Bishop was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
Ethics approval and consent to participate
No ethical approval was required for this study.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
List of benchmarks with consolidate survey answers.
Auxiliary summaries from the survey responses. Simulator used, secondary measures assessed, language of tools assessed.
About this article
Cite this article
Sonrel, A., Luetge, A., Soneson, C. et al. Meta-analysis of (single-cell method) benchmarks reveals the need for extensibility and interoperability. Genome Biol 24, 119 (2023). https://doi.org/10.1186/s13059-023-02962-5